What is rolapitant, and what does its “spiro patent” refer to?
Rolapitant is a medication candidate used for nausea and vomiting control, most commonly discussed in the context of antiemetic therapy. A phrase like “rolapitant spiro patent” usually points to intellectual-property claims tied to a particular chemical scaffold or structural form described as a “spiro” (spirocyclic) structure in a patent document, rather than a separate drug form. Without a specific patent number, assignee, or jurisdiction, the exact scope of “spiro” claims can’t be pinned to one family.
If you share the patent number (or the applicant/assignee name and publication year), I can summarize that specific “spiro” patent more precisely.
How do you synthesize a rolapitant “spiro” claim (practical patent-synthesis view)?
A patent synthesis in chemistry/IP terms usually combines three layers:
1. Claim target: what the patent claims (a spirocyclic compound, an intermediate, a salt, a process step, or a specific method of making/using).
2. Key structural elements: which part of the molecule the “spiro” portion covers (the spiro ring system and how substituents are defined).
3. Synthetic route: which building blocks and transformations the patent uses to make that spiro motif (e.g., how the spiro ring is constructed, then how the rest of the rolapitant framework is assembled, and finally how salts or stereochemistry are handled).
To do that accurately, we need the actual document(s) describing the spiro scaffold and the examples tied to rolapitant’s structure.
What do patent “synthesis” sections typically reveal about a rolapitant spiro intermediate?
If the patent includes an Examples/Preparation section, it commonly discloses:
- The spirocyclic core construction (the step where the spiro ring is formed and controlled).
- The functional group interconversions needed to reach rolapitant’s substitution pattern (installing or transforming side chains, heteroatoms, linkers).
- Purification and characterization (e.g., salt formation and analytical data that support identity and purity).
- Stereochemical handling (if applicable), including whether chirality is resolved or introduced by enantioselective steps.
That information is often enough to infer a high-level synthetic strategy even when full experimental details are long and equipment-specific.
Which patents are most likely to cover rolapitant spiro chemistry?
Rolapitant-related IP typically spans:
- Compound/substructure patents (covering the spirocyclic core as part of the full active compound).
- Process patents (covering how to make rolapitant, including spiro intermediates).
- Formulation or salt patents (if the “spiro” wording appears in a salt/intermediate context).
The best way to identify the “spiro patent” is to search within the patent text for “spiro” and then confirm the claims map back to rolapitant’s scaffold. But I can’t do that without the exact patent family identifiers or the source text.
What I need from you to produce the synthesis you’re asking for
Please provide at least one of the following:
- A patent number (e.g., US… / WO… / EP…)
- A publication link or the publication number
- The assignee/applicant name and approximate year
- The exact phrasing you saw (for example, the claim title or claim language that includes “spiro”)
Once you send that, I can produce a tight “rolapitant spiro patent synthesis” that summarizes:
- what the patent claims (compound/process/use),
- how the spiro motif is defined,
- the main synthetic steps in the example routes,
- and how the scope might differ across related documents in the same family.
Sources
No sources were provided in your prompt, and no specific patent document was named, so I can’t cite or accurately summarize a particular “rolapitant spiro patent” yet.